Navigation Links
Early Birds Save Up to $600 on Asian Biotech and Pharmaceutical Conferences
Date:7/12/2012

FARMINGTON, Conn., July 12, 2012 /PRNewswire-iReach/ -- Successful businesses stay connected to the biotech market, network, and forge new business relationships with industry leaders at global biotech conferences with help from Global Information Inc. Attendees go to learn about new innovations, how to implement effective strategies, and tactics for minimizing costs and risks while overcoming regulatory and technological hurdles.

(Photo: http://photos.prnewswire.com/prnh/20120712/CG39694)

Global Information announces limited early bird registrations for three important biotech and pharmaceutical conferences in Shanghai and Singapore.

Bio World China 2012

November 5 – 7, 2012 – Shanghai, China

Facilitate innovation and manufacturing of affordable and high quality vaccine and biopharmaceutical drugs in China. This conference is China's largest biopharmaceutical industry gathering of decision makers across C-level management in the realms of biologics, biosimilars, vaccines and blood/plasma products. Bio World China 2012 will feature over 50 CEOs from China's major biopharmaceutical companies, 300+ senior decision makers from all major biopharmaceutical players from China and globally, 50+ case studies ranging from investments, cell culture engineering, blood product developments, vaccines industry trends and R&D updates, stem cell technologies and biomanufacturing best practices. Additionally, ample networking time ensures quality face time to forge lasting business relationships.

Save $600 by registering before July 31! More information available at http://www.giiconference.com/ima236697-2012/

Biologic Manufacturing China 2012

October 17 – 18, 2012 – Shanghai, China

The face of the biopharmaceutical sector is changing substantially, with rapid developments in both developed countries and emerging markets. By 2016, biologic therapeutics are forecast to account for 23% of the global medicine market creating a market of USD 158 billion.

Compared to chemical drug manufacturing, biologic manufacturers are challenged with more complex processes and stringent regulatory requirements. Better planning, more investment and more sophisticated knowledge of the technologies are required in both early development and scale up projects to achieve desired results. Biologic Manufacturing China 2012 has all the answers companies are looking for whether in early stage development, maturing into scale up manufacturing, or a mature international organization.

Register before August 10 and save $400! More information is available at http://www.giiconference.com/iqpc243588-2012/

2nd Annual Clinical Trial Supply Asia

October 15 – 16, 2012 – Singapore

With the surge in the clinical services market and an increase in demand for clinical logistics in Asia, three major challenges confront the clinical trial supply in Asia this year: 1) Regulatory affairs; 2) Cost and quality; and 3) Temperature controlled distribution. The 2nd Annual Clinical Trial Supply Asia 2012 summit will cover these three topics and more. This event is Asia's leading high-level platform for clinical trial supply directors and clinical trial project managers from leading pharmaceutical companies, biopharmaceutical companies and CROs. Attendees will hear what industry leaders have to say about implementing effective clinical trial supply strategies in Asia to achieve successful on-time delivery and minimize costs and risks.

Save up to $640 by registering before August 10!  More information is available at http://www.giiconference.com/iqpc246344-2012/

About Global Information Inc. Global Information (GII) (http://www.giiresearch.com) is an information service company partnering with over 300 research companies around the world. Global Information has been in the business of distributing technical and market research for more than 25 years. Expanded from its original headquarters in Japan, Global Information now has offices in Korea, Taiwan, Singapore, Europe and the United States.

Media Contact: Jeremy Palaia Global Information, Inc., 1-860-674-8796, Press@gii.co.jp

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Global Information, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Nearly 300 Medical Device, Healthcare Professionals Attend First National Conference on Value-driven Engineering
2. Accuray Launches First Study to Compare CyberKnife® SBRT to Surgery and IMRT for Treatment of Early-Stage Prostate Cancer
3. Evergreen Healthcare Foundation Gala Raises Nearly $1.1 Million to Benefit Breast Health Center
4. Retrospective Study Suggests that Stereotactic Ablative Radiotherapy (SABR) Can be a Viable Option for Treating Early-Stage Lung Cancer in Operable as well as Inoperable Patients; Phase III Randomized Trial Now Under Way
5. Islet Sciences Announces Exclusive License Agreement with Yale University to Commercialize an Early Beta Cell Destruction and Diabetes Diagnostic
6. Early Coronary Artery Healing Advantage of OrbusNeichs Combo Dual Therapy Stent™ Compared to the TAXUS® Stent Shown in Two Clinical Trial Subgroup Analyses
7. Varian Medical Systems to Showcase Radiosurgery Technology for Non-invasive Treatment of Early Stage Inoperable Lung Cancer
8. joimax® at the Early Summer Congresses: SpineWeek Amsterdam and DGNC Leipzig
9. Senate to Vote on Final FDA User Fee Bill As Early As Today
10. GenWay Biotech Appoints New Vice President of Custom/OEM
11. Amarantus BioSciences to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/6/2017)... WILMINGTON, Del. , Sept. 6, 2017 NeuroRx, ... for Acute Suicidal Ideation and Behavior (ASIB), has been granted ... for its sequential therapy of NRX-100 (ketamine HCl) followed by ... patients in a pivotal trial of this sequential therapy targeting ... bipolar depression. 1 ...
(Date:9/5/2017)... Pa. , Sept. 5, 2017  Xyntek Inc. has announced another milestone ... a new Midwest office to meet the growing demands of customer engagements regionally.  ... Xyntek's new Midwest office is located at 318 ... ... of customer engagements regionally. ...
(Date:9/5/2017)... Sept. 5, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... clinical-stage pharmaceutical company focused on the development of oral ... concluded its meeting with the U.S. Food and Drug ... formulation. At the ... pathway for submission of ORMD-0801, would be a Biologics ...
Breaking Medicine Technology:
(Date:9/21/2017)... ... September 21, 2017 , ... Preora Diagnostics Inc. ... screening tests, has received two prestigious recognitions that acknowledge the promise of its ... Preora has been named a Top 100 Finalist for the 16th annual ...
(Date:9/21/2017)... ... September 21, 2017 , ... FlipBelt, the fitness brand ... to detail to the athletic wear market with the launch of their FlipBelt Crops. ... have their essentials securely at their fingertips while at the gym, on the trail, ...
(Date:9/21/2017)... ... September 21, 2017 , ... ... Month, Lewis and Clark College Emeritus Professor of Education Gregory A. Smith examines ... of Asleep at the Switch: Schoolhouse Commercialism, Privacy, and the Failure of ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... Coating System for clients that rely on safety and cleanliness. This unique flooring ... , Silver has been used for centuries for its antimicrobial properties. Unlike antibiotics, ...
(Date:9/20/2017)... ... ... Doctors on Liens has added the medical group Bones and Spine Surgery, ... personal injury lien basis. Founded by Dr. Wayne Cheng, MD and Dr. Gordon Yee, ... orthopedic injuries to patients in the Inland Empire. , Bones and Spines Surgery Inc ...
Breaking Medicine News(10 mins):